Is Laboratory Stock a Good Investment?

Laboratory Investment Advice

To provide specific investment advice or recommendations on Laboratory of stock, we recommend investors consider the following general factors when evaluating Laboratory of. This will help you to make an informed decision on whether to include Laboratory in one of your diversified portfolios:

Examine Laboratory's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Laboratory's leadership team and their track record. Good management can help Laboratory navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact Laboratory's business and its evolving consumer preferences.
Compare Laboratory's performance and market position to its competitors. Analyze how Laboratory is positioned in terms of product offerings, innovation, and market share.
Check if Laboratory pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Laboratory's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Laboratory of stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Laboratory of is a good investment.

Sell

Buy

Hold

Macroaxis provides trade recommendations on Laboratory to complement and cross-verify current analyst consensus on Laboratory. Our advice engine determines the firm's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Laboratory is not overpriced, please verify all Laboratory of fundamentals, including its shares outstanding, gross profit, book value per share, as well as the relationship between the price to earning and cash per share . Given that Laboratory has a price to earning of 12.69 X, we recommend you to check Laboratory market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Market Performance	Modest	Details
Volatility	Very steady	Details
Hype Condition	Low key	Details
Current Valuation	Overvalued	Details
Odds Of Distress	Very Low	Details
Economic Sensitivity	Follows the market closely	Details
Investor Sentiment	Alarmed	Details
Analyst Consensus	Strong Buy	Details
Financial Strenth (F Score)	Strong	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Possible Manipulator	Details

Examine Laboratory Stock

Researching Laboratory's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 95.0% of the company shares are owned by institutional investors. The book value of Laboratory was now reported as 97.61. The company has Price/Earnings To Growth (PEG) ratio of 0.51. Laboratory recorded earning per share (EPS) of 5.28. The entity last dividend was issued on the 26th of November 2024. The firm had 1164:1000 split on the 3rd of July 2023.

To determine if Laboratory is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Laboratory's research are outlined below:

	Laboratory has a strong financial position based on the latest SEC filings
	Over 95.0% of the company shares are owned by institutional investors
	On 26th of November 2024 Laboratory paid $ 0.72 per share dividend to its current shareholders
	Latest headline from gurufocus.com: Insider Sell van der Vaart Sandra D Sells 1,000 Shares of Labcorp Holdings Inc

Laboratory Quarterly Cost Of Revenue

2.38 Billion

Laboratory uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Laboratory of. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Laboratory's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	15th of February 2024 Upcoming Quarterly Report	View
	23rd of April 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	15th of February 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Earnings surprises can significantly impact Laboratory's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Laboratory's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
1997-07-29	1997-06-30	0.06	0.05	-0.01	16
1999-07-22	1999-06-30	0.13	0.15	0.02	15
1998-03-17	1997-12-31	-0.12	-0.1	0.02	16
1998-10-27	1998-09-30	-0.02	0.002	0.022	110
2000-10-23	2000-09-30	0.2	0.24	0.04	20
1997-10-28	1997-09-30	-0.07	-0.12	-0.05	71
1997-04-25	1997-03-31	0.1	0.05	-0.05	50
1996-04-25	1996-03-31	0.19	0.13	-0.06	31

Know Laboratory's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Laboratory is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Laboratory of backward and forwards among themselves. Laboratory's institutional investor refers to the entity that pools money to purchase Laboratory's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

		Shares
Dimensional Fund Advisors, Inc.	2024-09-30	1.4 M
Amvescap Plc.	2024-06-30	1.3 M
Veritas Investment Partners (uk) Ltd.	2024-09-30	1.2 M
Norges Bank	2024-06-30	1 M
Northern Trust Corp	2024-09-30	1 M
Nordea Investment Mgmt Bank Demark A/s	2024-09-30	984 K
Bank Of America Corp	2024-06-30	978.1 K
Cooke & Bieler Lp	2024-09-30	942.1 K
Ubs Asset Mgmt Americas Inc	2024-09-30	914 K
Vanguard Group Inc	2024-09-30	9.6 M
Blackrock Inc	2024-06-30	9.5 M

Note, although Laboratory's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Laboratory's market capitalization trends

The company currently falls under 'Large-Cap' category with a market capitalization of 19.97 B.

Market Cap

16.08 Billion

Laboratory's profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	0.06	0.05
Return On Capital Employed	0.05	0.05
Return On Assets	0.02	0.02
Return On Equity	0.05	0.05

The company has Net Profit Margin (PM) of 0.03 %, which suggests that even a small decline in it sales will erase profits and may result in a net loss, or a negative profit margin. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.08 %, which signifies that for every $100 of sales, it has a net operating income of $0.08.

Determining Laboratory's profitability involves analyzing its financial statements and using various financial metrics to determine if Laboratory is a good buy. For example, gross profit margin measures Laboratory's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Laboratory's profitability and make more informed investment decisions.

Evaluate Laboratory's management efficiency

Laboratory has Return on Asset (ROA) of 0.0396 % which means that for every $100 of assets, it generated a profit of $0.0396. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.0543 %, which means that it produced $0.0543 on every 100 dollars invested by current stockholders. Laboratory's management efficiency ratios could be used to measure how well Laboratory manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to 0.05. The current Return On Capital Employed is estimated to decrease to 0.05. As of now, Laboratory's Total Current Assets are increasing as compared to previous years. The Laboratory's current Other Assets is estimated to increase to about 531.7 M, while Non Currrent Assets Other are projected to decrease to under 270.8 M.

	Last Reported	Projected for Next Year
Book Value Per Share	90.59	95.12
Tangible Book Value Per Share	(18.30)	(19.22)
Enterprise Value Over EBITDA	18.74	10.82
Price Book Value Ratio	2.51	3.28
Enterprise Value Multiple	18.74	10.82
Price Fair Value	2.51	3.28
Enterprise Value	7.4 B	7.8 B

Examining the leadership quality of Laboratory of offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.

Dividend Yield

0.0121

Forward Dividend Yield

0.0121

Forward Dividend Rate

2.88

Beta

1.036

Basic technical analysis of Laboratory Stock

As of the 28th of November, Laboratory secures the Downside Deviation of 1.28, mean deviation of 0.9341, and Risk Adjusted Performance of 0.0472. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Laboratory, as well as the relationship between them.

Laboratory's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Laboratory insiders, such as employees or executives, is commonly permitted as long as it does not rely on Laboratory's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Laboratory insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Akinbolade Oyegunwa over three weeks ago Acquisition by Akinbolade Oyegunwa of 1110 shares of Laboratory subject to Rule 16b-3
		Glenn Eisenberg over three months ago Disposition of 9071 shares by Glenn Eisenberg of Laboratory at 224.5488 subject to Rule 16b-3
		Peter Wilkinson over three months ago Disposition of 894 shares by Peter Wilkinson of Laboratory at 216.57 subject to Rule 16b-3
		Glenn Eisenberg over three months ago Disposition of 18379 shares by Glenn Eisenberg of Laboratory at 215.3661 subject to Rule 16b-3
		Rothman Paul over three months ago Acquisition by Rothman Paul of 717 shares of Laboratory subject to Rule 16b-3
		Lance Berberian over six months ago Disposition of 3299 shares by Lance Berberian of Laboratory at 216.57 subject to Rule 16b-3
		Van Der Vaart Sandra D over six months ago Disposition of 200 shares by Van Der Vaart Sandra D of Laboratory at 210.835 subject to Rule 16b-3
		Peter Wilkinson over six months ago Payment of tradable shares by Peter Wilkinson of Laboratory subject to Rule 16b-3
		Peter Wilkinson over six months ago Exercise or conversion by Peter Wilkinson of 131 shares of Laboratory subject to Rule 16b-3
		Peter Wilkinson over a year ago Sale by Peter Wilkinson of 1384 shares of Laboratory
		Peter Wilkinson over a year ago Payment of tradable shares by Peter Wilkinson of Laboratory subject to Rule 16b-3

Laboratory's Outstanding Corporate Bonds

Laboratory issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Laboratory uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Laboratory bonds can be classified according to their maturity, which is the date when Laboratory of has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	Dana 575 percent Corp Bond US235822AB96	View
	Volcan Compania Minera Corp Bond USP98047AC08	View
	Boeing Co 2196 Corp Bond US097023DG73	View
	HSBC Holdings PLC Corp Bond US404280DR76	View
	MPLX LP 4875 Corp Bond US55336VAG59	View
	MPLX LP 4125 Corp Bond US55336VAK61	View
	MPLX LP 52 Corp Bond US55336VAL45	View
	International Game Technology Corp Bond US460599AD57	View

View All Laboratory Corporate Bonds

Understand Laboratory's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Laboratory's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.0472
	Market Risk Adjusted Performance	0.1084
	Mean Deviation	0.9341
	Semi Deviation	1.17
	Downside Deviation	1.28
	Coefficient Of Variation	1771.76
	Standard Deviation	1.29
	Variance	1.65
	Information Ratio	(0.04)
	Jensen Alpha	(0.01)
	Total Risk Alpha	(0.14)
	Sortino Ratio	(0.05)
	Treynor Ratio	0.0984
	Maximum Drawdown	7.89
	Value At Risk	(1.83)
	Potential Upside	2.1
	Downside Variance	1.65
	Semi Variance	1.37
	Expected Short fall	(0.92)
	Skewness	0.3884
	Kurtosis	2.1

	Risk Adjusted Performance	0.0472
	Market Risk Adjusted Performance	0.1084
	Mean Deviation	0.9341
	Semi Deviation	1.17
	Downside Deviation	1.28
	Coefficient Of Variation	1771.76
	Standard Deviation	1.29
	Variance	1.65
	Information Ratio	(0.04)
	Jensen Alpha	(0.01)
	Total Risk Alpha	(0.14)
	Sortino Ratio	(0.05)
	Treynor Ratio	0.0984
	Maximum Drawdown	7.89
	Value At Risk	(1.83)
	Potential Upside	2.1
	Downside Variance	1.65
	Semi Variance	1.37
	Expected Short fall	(0.92)
	Skewness	0.3884
	Kurtosis	2.1

Consider Laboratory's intraday indicators

Laboratory intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Laboratory stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	649.84
	Rate Of Daily Change	1.0
	Day Median Price	240.44
	Day Typical Price	241.01
	Market Facilitation Index	1.0E-4
	Price Action Indicator	1.71
	Relative Strength Index	77.17

Laboratory Corporate Filings

F4	26th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities	View Verify
8K	19th of November 2024 Report filed with the SEC to announce major events that shareholders should know about	View Verify
F3	4th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock	View Verify
10Q	29th of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations	View Verify

Laboratory time-series forecasting models is one of many Laboratory's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Laboratory's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Laboratory Stock media impact

Far too much social signal, news, headlines, and media speculation about Laboratory that are available to investors today. That information is available publicly through Laboratory media outlets and privately through word of mouth or via Laboratory internal channels. However, regardless of the origin, that massive amount of Laboratory data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of Laboratory news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Laboratory relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Laboratory's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Laboratory alpha.

Laboratory Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Laboratory can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Laboratory Historical Investor Sentiment

Investor biases related to Laboratory's public news can be used to forecast risks associated with an investment in Laboratory. The trend in average sentiment can be used to explain how an investor holding Laboratory can time the market purely based on public headlines and social activities around Laboratory of. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Laboratory's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Laboratory and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Laboratory news discussions. The higher the estimate score, the more favorable the investor's outlook on Laboratory.